Promising trial results support marketing authorisation application
This woman in her early 50s with a background of neurofibromatosis type 1 (NF1) presented with a seven […]
We’re stuck in a vicious cycle. Hospital beds are full. Over 12% of hospital inpatients no longer meet […]
Weak health systems, increasing drug resistance, and funding shortages are impeding progress towards eliminating malaria, as cases rise […]
We’ve been shaken recently in our surgery by some unexpected diagnoses and sudden deaths that have reminded us […]
Updated Date: Tue, 03 Dec 2024 00:00:00 EST
Successful phase 1 study highlights potential of roginolisib
Promising results set stage for European marketing authorization
Updated Date: Tue, 03 Dec 2024 00:00:00 EST